Gene: ANKRD46
Official Full Name: ankyrin repeat domain 46provided by HGNC
Gene Summary: This gene encodes a protein containing multiple ankyrin repeats. Ankyrin domains function in protein-protein interactions in a variety of cellular processes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19820 | ANKRD46 Knockout cell line (HeLa) | Human | ANKRD46 | 1:3~1:6 | Negative | Online Inquiry |
KO19821 | ANKRD46 Knockout cell line (HCT 116) | Human | ANKRD46 | 1:2~1:4 | Negative | Online Inquiry |
KO19822 | ANKRD46 Knockout cell line (HEK293) | Human | ANKRD46 | 1:3~1:6 | Negative | Online Inquiry |
KO19823 | ANKRD46 Knockout cell line (A549) | Human | ANKRD46 | 1:3~1:4 | Negative | Online Inquiry |
ANKRD46 Gene Knockout Cell Lines are genetically engineered cell models designed to specifically knock out the ANKRD46 gene, which encodes a protein involved in immune system regulation and cellular signaling pathways. These cell lines provide researchers with a powerful tool for studying the functional role of ANKRD46 in various biological processes, including T-cell activation and differentiation, as well as its implications in disease states such as autoimmune disorders and cancer.
The key function of the ANKRD46 Gene Knockout Cell Lines lies in their ability to help dissect the molecular mechanisms of gene function through the observation of phenotypic changes upon gene disruption. By eliminating the expression of ANKRD46, researchers can explore alterations in cellular behavior, signaling cascades, and gene expression profiles, allowing for the identification of downstream effects and potential therapeutic targets. This makes the product invaluable for both basic research and translational studies, as it helps illuminate the role of immune regulation in health and disease.
From a scientific standpoint, these knockout cell lines have significant applications in research settings, including drug development, toxicity screening, and the evaluation of gene therapy strategies. Their use can accelerate the understanding of complex biological interactions and the identification of novel biomarkers, ultimately enhancing the potential for clinical applications.
A significant advantage of our ANKRD46 Gene Knockout Cell Lines over alternative models is their robustness and reproducibility, ensuring consistent results across experiments. Furthermore, they are crafted with precision using advanced CRISPR-Cas9 technology, which increases the accuracy of gene editing compared to traditional methods. End-users can expect high quality and well-characterized cell lines that comply with rigorous research standards.
In conclusion, the ANKRD46 Gene Knockout Cell Lines present a unique and valuable resource for researchers and clinicians alike, enabling groundbreaking discoveries in immunology and gene function. Our commitment to excellence in producing high-quality biological products ensures that you have access to the latest innovations in cell line technology, enhancing the efficacy of your research and therapeutic endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.